Case series:meropenem

2 trials

Sponsors

The Second Xiangya Hospital of Central South University, The Second Hospital of Dalian Medical University

Conditions

Meropenem for CAP\HAP\VAPpulmonary infection

Phase 4

Population pharmacokinetics and pharmacodynamics of meropenem in patients with severe pulmonary infection

RecruitingChiCTR1900020672

The Second Xiangya Hospital of Central South Universitypulmonary infection

Start: 2019-01-21Updated: 2019-01-14

Unknown Phase

Study for meropenem in the treatment of CAP\HAP\VAP and clinical decision support of based on AI deep learning algorithm

Active, not recruitingChiCTR2000029190

The Second Hospital of Dalian Medical UniversityMeropenem for CAP\HAP\VAP

Start: 2020-01-18Updated: 2020-01-20

Related Papers

Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients.

2021-11-0616 citations